Danielle L. Rodin

Radiation Oncology

75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Journal: Leukemia & lymphoma

Published: June 15, 2026

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

Journal: JAMA network open

Published: April 01, 2026

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

A Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma.

Journal: Current oncology (Toronto, Ont.)

Published: March 30, 2026

Creating Sustainable Education Programming to Build Capacity for Collaborative Global Cancer Control.

Creating Sustainable Education Programming to Build Capacity for Collaborative Global Cancer Control.

Journal: JCO global oncology

Published: March 19, 2026

Global Approach to Oncology Leadership: The GOLD Program.

Global Approach to Oncology Leadership: The GOLD Program.

Journal: JCO global oncology

Published: March 17, 2026

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting.

Journal: British journal of haematology

Published: February 25, 2026

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Journal: Clinical and translational radiation oncology

Published: February 23, 2026

Pilot Health Care Provider Education Program for BRCA1/2 Genetic Testing, Counseling, and Management in Nigeria.

Pilot Health Care Provider Education Program for BRCA1/2 Genetic Testing, Counseling, and Management in Nigeria.

Journal: JCO global oncology

Published: January 15, 2026

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

Journal: British journal of haematology

Published: December 29, 2025

The Impact of Ontario's Virtual Care Payment Model on Cancer Care: A Natural Policy Experiment.

The Impact of Ontario's Virtual Care Payment Model on Cancer Care: A Natural Policy Experiment.

Journal: Journal of medical Internet research

Published: December 07, 2025

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Outcomes of Bridging Therapy in Patients With Relapsed/Refractory Large B Cell Lymphoma Receiving Third-Line CAR T.

Journal: Hematological oncology

Published: November 03, 2025

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Journal: Leukemia & lymphoma

Published: November 03, 2025

Showing 1-12 of 123

Last Updated: 09/26/2026